rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AVR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Anteris Technologies advances PARADIGM trial and manufacturing scale-up in third quarter

      Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) continued to advance its pivotal PARADIGM Trial and expand manufacturing capacity in the third quarter of 2026 as it prepares to commercialise the DurAVR transcatheter heart valve system. The global healthcare company said patient recruitment...

      Nov 10Yahoo FinanceAVR
      Anteris Technologies reports strong 30-day DurAVR heart valve outcomes from EMBARK Study

      Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has reported encouraging 30-day clinical and haemodynamic results for the medium-size DurAVR transcatheter heart valve (THV), including low pressure gradients, large valve openings and no valve-related deaths. Results from 22 patients with...

      Nov 1Yahoo FinanceAVR
      Small Cap watch: ASX small caps ease after strong week as NewPeak, Orthocell and Anteris advance drilling, sales and data

      The S&P/ASX Small Ordinaries Index (AXS: XSO) ended Friday at 3,147.90 points, down 23.50 points or 0.74%. Despite the weaker session, the small-cap benchmark remained higher over the week, gaining 92.50 points or 3.03% across the past five trading days. We expect a quiet styart to the...

      Nov 1Yahoo FinanceAVR
      Anteris Technologies Wins German Clearance for Heart Valve Trial
      Oct 20Yahoo FinanceAVR
      Anteris Technologies secures German clearance to expand PARADIGM heart valve trial
      Oct 20Yahoo FinanceAVR
      Cantor Fitzgerald reiterates Anteris Technologies stock rating at Overweight
      Oct 14Investing.comAVR
      Anteris Extends Key Supply and Quality Agreement Term

      Detailed price information for Anteris Technologies Global Corp (AVR-Q) from The Globe and Mail including charting and trades.

      Sep 24The Globe and MailAVR
      Anteris Technologies Enhances Executive Equity-Based Compensation Plans

      Detailed price information for Anteris Technologies Global Corp (AVR-Q) from The Globe and Mail including charting and trades.

      Sep 18The Globe and MailAVR
      Anteris Technologies Global Appoints New Chief Financial Officer

      Detailed price information for Anteris Technologies Global Corp (AVR-Q) from The Globe and Mail including charting and trades.

      Sep 9The Globe and MailAVR
      Anteris Technologies appoints Brent Moen as chief financial officer

      Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed experienced financial executive Brent Moen as chief financial officer, effective September 12, 2026 AEST. Moen brings more than 25 years of leadership experience across public and private companies, with expertise spanning...

      Sep 6Yahoo FinanceAVR
      Anteris to Present at September Healthcare Investor Conferences

      MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, is pleased to advise that Vice Chairman and Chief Executive Officer, Wayne Paterson, will be presenting at the Cantor Global Healthcare Conference, the Wells Fargo 21st Annual Healthcare Confere

      Aug 31Yahoo FinanceAVR

      This is the newest page. Registered accounts read further back.